SEC Filing Summary

Robert M. VanHimbergen, EVP and CFO of Elanco Animal Health Inc, acquired 8.7877 Deferred Stock Units with a price per share of $22.42. The transaction date was September 18, 2026, and the post-transaction shares owned are 158.6535. Each unit represents the right to receive one share of Company common stock or its cash equivalent. These units settle in cash or shares following termination of employment or during a specified future year. The filing is Form 4, signed by Amy C. Seidel as Attorney-in-Fact for Robert M. VanHimbergen on September 22, 2026.